Chem. J. Chinese Universities ›› 2016, Vol. 37 ›› Issue (7): 1287.doi: 10.7503/cjcu20160295

• Organic Chemistry • Previous Articles     Next Articles

Design, Sythesis and Biological Evaluation of Polyphenol-α-helical Peptide Conjugates as Potent HIV-1 Fusion Inhibitors

CHENG Siqi1, LIANG Guodong2, JIANG Xifeng2, WANG Chao2,*(), LIU Keliang1,2,*()   

  1. 1. School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China
    2. Beijing Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing 100850, China
  • Received:2016-04-29 Online:2016-07-10 Published:2016-06-22
  • Contact: WANG Chao,LIU Keliang E-mail:chaow301@gmail.com;keliangliu55@126.com
  • Supported by:
    † Supported by the National Natural Science Foundation of China(Nos.81573266, 81373266)

Abstract:

De novo-designed peptide sequences with an α-helical conformation can prevent fusogenic gp41 six-helical bundle(6HB) formation by specifically interacting with the Human Immunodificiency virus type 1(HIV-1) gp41 N-terminal heptad repeat(NHR) region, thus inhibiting HIV-1-cell membrane fusion. Meanwhile, polyphenols, such as hydroxytyrosol(HT) and (-)-epigallocatechin gallate(EGCG), are a major group of natural compounds with a broad spectrum of antiviral activity. In this paper, mHT were designed and obtained based on 3,4-dihydroxymethylacetic acid. Then, mHT and other bioactive polyphenols, were covalently conjugated to a certain α-helical peptide through specific linkers with different lengths and flexibilities. These conjugates interacted with the gp41 NHR region and exhibited promising fusion inhibitory activity, with IC50 values in the low micromolar range. This study provides a promising strategy for the development of fusion inhibitors against viruses with class I fusion proteins.

Key words: Human immunodificiency virus type 1(HIV-1), Fusion inhibitor, α-Helical peptide, Polyphenol

CLC Number: 

TrendMD: